x

PROVECTUS BIOPHARMACEUTICALS, INC. (OTC:PVCT)

N/A • N/A
CIK 315545
Company

N/A

Address
N/A
Employees
None
Stock Info
Close
N/A
Day Range
N/A
52 Week Range
N/A
Average volume
N/A
Short Interest
N/A (N/A)
% of Float Shorted
N/A
Market Cap
N/A
Revenue
N/A
Net Income
N/A
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
N/A
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
SEC filings
DateFormEvent
11 Dec, 2024 8-K
6 Dec, 2024 SC 13D/A
5 Dec, 2024 8-K
4 Dec, 2024 4
4 Dec, 2024 4
4 Dec, 2024 4
4 Dec, 2024 4
4 Dec, 2024 4
4 Dec, 2024 4
2 Dec, 2024 4
25 Nov, 2024 4
14 Nov, 2024 8-K
12 Nov, 2024 10-Q
17 Oct, 2024 4
30 Sep, 2024 4
30 Sep, 2024 4
30 Sep, 2024 4
30 Sep, 2024 4
30 Sep, 2024 4
20 Sep, 2024 4
30 Aug, 2024 4
27 Aug, 2024 4
19 Aug, 2024 8-K
14 Aug, 2024 4
14 Aug, 2024 SC 13G
13 Aug, 2024 10-Q
9 Aug, 2024 4
5 Aug, 2024 4
23 Jul, 2024 4
22 Jul, 2024 4
19 Jul, 2024 4
17 Jul, 2024 8-K
17 Jul, 2024 D
3 Jul, 2024 SC 13D
2 Jul, 2024 4
1 Jul, 2024 4
25 Jun, 2024 8-K
21 Jun, 2024 8-K
21 Jun, 2024 4
20 Jun, 2024 DEFA14A
20 Jun, 2024 8-K
17 Jun, 2024 4
28 May, 2024 4
14 May, 2024 10-Q
13 May, 2024 4
9 May, 2024 ARS
6 May, 2024 DEFA14A
6 May, 2024 DEF 14A
30 Apr, 2024 4
29 Apr, 2024 10-K/A
26 Apr, 2024 PRE 14A
26 Apr, 2024 4
22 Apr, 2024 4
16 Apr, 2024 8-K CEO Change
15 Apr, 2024 4
9 Apr, 2024 4
28 Mar, 2024 10-K
27 Mar, 2024 8-K
26 Mar, 2024 4
26 Mar, 2024 8-K
22 Mar, 2024 4
18 Mar, 2024 4
29 Feb, 2024 4
28 Feb, 2024 4
28 Feb, 2024 4
22 Feb, 2024 8-K
20 Feb, 2024 4
16 Feb, 2024 4
15 Feb, 2024 8-K
6 Feb, 2024 4
1 Feb, 2024 4
29 Jan, 2024 4
12 Jan, 2024 4
29 Dec, 2023 4
22 Dec, 2023 4
20 Dec, 2023 4
4 Dec, 2023 4
30 Nov, 2023 4
15 Nov, 2023 4
14 Nov, 2023 10-Q
13 Nov, 2023 4
1 Nov, 2023 4
27 Oct, 2023 4
19 Oct, 2023 4
5 Oct, 2023 4
14 Aug, 2023 10-Q
14 Aug, 2023 4
4 Aug, 2023 4
28 Jul, 2023 4
26 Jul, 2023 4
24 Jul, 2023 4
5 Jul, 2023 4
22 Jun, 2023 8-K
21 Jun, 2023 8-K
21 Jun, 2023 DEFA14A
16 Jun, 2023 4
30 May, 2023 4
15 May, 2023 4
11 May, 2023 ARS
11 May, 2023 10-Q
9 May, 2023 4
9 May, 2023 SC 13G
1 May, 2023 DEF 14A
1 May, 2023 DEFA14A
26 Apr, 2023 4
21 Apr, 2023 PRE 14A
17 Apr, 2023 8-K
10 Apr, 2023 4
30 Mar, 2023 10-K
28 Mar, 2023 SC 13G
28 Mar, 2023 3
21 Mar, 2023 4
22 Feb, 2023 4
30 Jan, 2023 4
12 Jan, 2023 4
9 Jan, 2023 8-K
12 Dec, 2022 8-K
5 Dec, 2022 4
17 Nov, 2022 4
15 Nov, 2022 4
9 Nov, 2022 10-Q
2 Nov, 2022 4
28 Oct, 2022 4
28 Oct, 2022 D
26 Sep, 2022 8-K
20 Sep, 2022 4
12 Aug, 2022 4
11 Aug, 2022 10-Q
23 Jun, 2022 8-K
22 Jun, 2022 8-K
22 Jun, 2022 DEFA14A
6 Jun, 2022 DEFA14A
26 May, 2022 DEFA14A
19 May, 2022 DEFA14A
12 May, 2022 10-Q
29 Apr, 2022 DEF 14A
29 Apr, 2022 DEFA14A
19 Apr, 2022 PRE 14A
19 Apr, 2022 8-K
5 Apr, 2022 8-K
29 Mar, 2022 10-K
10 Nov, 2021 10-Q
7 Sep, 2021 8-K
30 Aug, 2021 D
18 Aug, 2021 4
18 Aug, 2021 8-K
12 Aug, 2021 10-Q
30 Jun, 2021 SC 13D
28 Jun, 2021 8-K
24 Jun, 2021 8-K
23 Jun, 2021 8-K
22 Jun, 2021 4
22 Jun, 2021 4
22 Jun, 2021 4
22 Jun, 2021 4
22 Jun, 2021 4
11 May, 2021 10-Q
29 Apr, 2021 DEF 14A
29 Apr, 2021 DEFA14A
2 Mar, 2021 10-K
We don't have more information about this company at this moment.
Last update:None
PROVECTUS BIOPHARMACEUTICALS, INC. by TradingView

Sign Up to Subscribe